Montana Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 11 (79% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,614
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 12.76%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 360
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 16.33%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 72.00% 68.33%
White, Hispanic/Latino Patients 3.04% 5.00%
Black/African American, Non-Hispanic/Latino Patients 0.93% 0.83%
Black/African American, Hispanic/Latino Patients 0.00% 0.00%
Asian Patients3 0.37% 0.56%
American Indian/Alaska Native Patients3 3.90% 6.11%
Native Hawaiian/Other Pacific Islander Patients3 0.19% 0.28%
Patients with More than one race3 1.73% 0.28%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.37% 0.28%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.99% 1.39%
Unreported/Refused to Report Race and Ethnicity 16.48% 16.94%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 191
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 26.03%
COVID-19 Immunization Series Completed 256
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 17.99%
COVID-19 Immunization Series Additional 426
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 6.50%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 56.54% 60.55% 53.99%
White, Hispanic/Latino Patients 5.76% 5.47% 1.64%
Black/African American, Non-Hispanic/Latino Patients 0.52% 0.39% 0.00%
Black/African American, Hispanic/Latino Patients 0.00% 0.00% 0.00%
Asian Patients3 1.57% 0.78% 0.94%
American Indian/Alaska Native Patients3 11.52% 5.86% 0.70%
Native Hawaiian/Other Pacific Islander Patients3 0.52% 0.00% 0.00%
Patients with More than one race3 0.00% 0.00% 0.23%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.00% 0.78% 0.23%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.00% 0.00% 0.00%
Unreported/Refused to Report Race and Ethnicity 23.56% 26.17% 42.25%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 18.18%
1 to 24 Hours 0.00%
More Than 24 Hours 81.82%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 9.09%
Staffing to administer the vaccine 27.27%
Vaccine confidence 36.36%
Vaccine storage capacity 9.09%
Vaccine supply 0.00%
Other 9.09%
None 27.27%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 8.64%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 18.18%
Number of Mobile Van Sites 4
Number of Pop-up Clinics 16
Number of School-Based Vaccination Sites 7

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 9.09%
Refer patients to another organization that provides monoclonal antibody therapies 45.45%
None 54.55%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 9.09%
Staffing capacity 18.18%
Therapy administration/onsite logistics 9.09%
Other 18.18%
None 45.45%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021